Shilpa Medicare witnessed a rise in share price on Monday after the company has received EU-GMP certification from Austrian Agency, AGES for its two API Manufacturing Plants located at Raichur, Karnataka and Formulation Facility located at Jadcherla, Telangana.

Austrian Agency, AGES carried out audit of said API plants between January 16 and January 24, 2018 and Formulation Facility between January 25 and January 31, 2018.

Shares of the company are trading at Rs 468.60, up Rs 15.95, or 3.52% at the Bombay Stock Exchange (BSE) on Monday at 12:11 p.m.

The scrip has touched an intra-day high of Rs 470.00 and low of Rs 460.00. The total volume of shares traded at the BSE is 2,661.

In the earlier session, the shares lost 2.58%, or Rs 12, at Rs 452.65. Currently, the stock is trading down 35.78% from its 52-week high of Rs 729.65 and above 16.86% over the 52-week low of Rs 401.00.